Literature DB >> 9585353

Pathogenesis of cortical myoclonus studied by magnetoencephalography.

T Mima1, T Nagamine, A Ikeda, S Yazawa, J Kimura, H Shibasaki.   

Abstract

Myoclonus-associated cortical activities were studied by simultaneous recording of a magnetoencephalogram and an electroencephalogram in 6 patients with cortical myoclonus due to various causes. Cortical activities were averaged, with respect to the precise onset of the myoclonic jerk, to evaluate the myoclonus-associated cortical magnetic fields. The estimated generator of their earliest peak was localized at the contralateral precentral gyrus in all patients. As judged from the direction of the electrical current, surface positive activity preceding the electromyographic discharge was detected in 3 patients with cortical reflex myoclonus and in 1 patient with possible corticobasal degeneration. In contrast, in the remaining 2 patients (Lennox-Gastaut syndrome and Alzheimer's disease), magnetic fields time-locked to the myoclonic jerk were associated with surface negative activity at the precentral cortex. The present study, applying for the first time an off-line jerk-locked back-averaging analysis to magnetoencephalography, demonstrated the important role of the precentral cortex in generating spontaneous myoclonus. It is most likely that the differing polarity of the electromagnetic activity reflects the differing activation patterns within the cortical laminar structure in the precentral area, underlying the generation of various types of myoclonus.

Entities:  

Mesh:

Year:  1998        PMID: 9585353     DOI: 10.1002/ana.410430507

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  Magnetoencephalography in the study of human somatosensory cortical processing.

Authors:  R Hari; N Forss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-07-29       Impact factor: 6.237

2.  Combined MEG-EEG source localisation in patients with sub-acute sclerosing pan-encephalitis.

Authors:  J Velmurugan; Sanjib Sinha; Madhu Nagappa; N Mariyappa; P S Bindu; G S Ravi; Nandita Hazra; K Thennarasu; V Ravi; A B Taly; P Satishchandra
Journal:  Neurol Sci       Date:  2016-04-07       Impact factor: 3.307

3.  Sensorimotor, visual, and auditory cortical atrophy in Unverricht-Lundborg disease mapped with cortical thickness analysis.

Authors:  P Koskenkorva; E Niskanen; J Hyppönen; M Könönen; E Mervaala; H Soininen; R Kälviäinen; R Vanninen
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

4.  Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.

Authors:  Tibor Kovács; Marianna Farsang; Edina Vitaszil; Péter Barsi; Tamás Györke; Imre Szirmai; Anita Kamondi
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

Review 5.  Myoclonus: An Electrophysiological Diagnosis.

Authors:  Shabbir Hussain I Merchant; Felipe Vial-Undurraga; Giorgio Leodori; Jay A van Gerpen; Mark Hallett
Journal:  Mov Disord Clin Pract       Date:  2020-06-17

6.  Giant early components of somatosensory evoked potentials to tibial nerve stimulation in cortical myoclonus.

Authors:  Francesca Anzellotti; Marco Onofrj; Laura Bonanni; Antonio Saracino; Raffaella Franciotti
Journal:  Neuroimage Clin       Date:  2016-07-02       Impact factor: 4.881

Review 7.  Myoclonic Disorders.

Authors:  Olaf Eberhardt; Helge Topka
Journal:  Brain Sci       Date:  2017-08-14

Review 8.  Cortical Mechanisms of Tongue Sensorimotor Functions in Humans: A Review of the Magnetoencephalography Approach.

Authors:  Hitoshi Maezawa
Journal:  Front Hum Neurosci       Date:  2017-03-28       Impact factor: 3.169

9.  Tremor after long term lithium treatment; is it cortical myoclonus?

Authors:  Ptolemaios Georgios Sarrigiannis; Panagiotis Zis; Zoe Charlotte Unwin; Daniel J Blackburn; Nigel Hoggard; Yifan Zhao; Stephen A Billings; Aijaz A Khan; John Yianni; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2019-05-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.